SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-19-007444
Filing Date
2019-03-13
Accepted
2019-03-12 21:52:14
Documents
97
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K insy-10k_20181231.htm 10-K 4824801
2 EX-21.1 insy-ex211_33.htm EX-21.1 6256
3 EX-23.1 insy-ex231_414.htm EX-23.1 4088
4 EX-31.1 insy-ex311_32.htm EX-31.1 9118
5 EX-31.2 insy-ex312_31.htm EX-31.2 8999
6 EX-32 insy-ex32_30.htm EX-32 9098
7 GRAPHIC grgxik3le5wp000002.jpg GRAPHIC 32568
8 GRAPHIC grgxik3le5wp000001.jpg GRAPHIC 10609
  Complete submission text file 0001564590-19-007444.txt   18394662

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT insy-20181231.xml EX-101.INS 5078169
10 XBRL TAXONOMY EXTENSION SCHEMA insy-20181231.xsd EX-101.SCH 72762
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE insy-20181231_cal.xml EX-101.CAL 86538
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE insy-20181231_def.xml EX-101.DEF 270723
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE insy-20181231_lab.xml EX-101.LAB 615534
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insy-20181231_pre.xml EX-101.PRE 510103
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35902 | Film No.: 19676992
SIC: 2834 Pharmaceutical Preparations